| 31. |
|
|
| 32. |
|
|
| 33. |
- Jern, Sverker, 1954, et al.
(författare)
-
Swedish Isradipine Study in Hypertension: evaluation of quality of life, safety, and efficacy. SWISH Group.
- 1991
-
Ingår i: Journal of cardiovascular pharmacology. - 0160-2446. ; 18 Suppl 3
-
Tidskriftsartikel (refereegranskat)abstract
- This was a double-blind multicenter study to compare the efficacy, tolerability and effects on the quality of life with isradipine and atenolol in the treatment of essential hypertension. Of 588 patients entering the 6-week placebo run-in period, 549 were eligible for randomization to receive either isradipine or atenolol for 8 weeks. If, at the end of this period, diastolic blood pressure (DBP) remained greater than 90 mm Hg, then both agents were given in combination for a further 10 weeks. Tolerability and quality of life were assessed repeatedly during the placebo and active-treatment phases. A subgroup of 30 patients were followed by 24-h ambulatory blood pressure monitoring, and their results are now being analyzed. In another subgroup of 26 patients, maximum exercise capacity, as determined by ergometer bicycle-testing, was measured once during placebo and twice during active treatment. At the end of the 24-week study period, both isradipine and atenolol as monotherapy had produced significant decreases in blood pressure. There were no significant differences overall between the compounds in quality-of-life and side-effect profiles, although there was a relative absence of ankle edema and headache with isradipine. Furthermore, patients receiving isradipine had no change in performance on exercise testing whereas patients on atenolol had a significant decrease (p less than 0.01).
|
|
| 34. |
- Kiviniemi, T., et al.
(författare)
-
A randomized prospective multicenter trial for stroke prevention by prophylactic surgical closure of the left atrial appendage in patients undergoing bioprosthetic aortic valve surgery––LAA-CLOSURE trial protocol
- 2021
-
Ingår i: American Heart Journal. - : Elsevier BV. - 0002-8703 .- 1097-6744. ; 237, s. 127-134
-
Tidskriftsartikel (refereegranskat)abstract
- Patients undergoing surgical aortic valve replacement (SAVR) are at high risk for atrial fibrillation (AF) and stroke after surgery. There is an unmet clinical need to improve stroke prevention in this patient population. The LAA-CLOSURE trial aims to assess the efficacy and safety of prophylactic surgical closure of the left atrial appendage for stroke and cardiovascular death prevention in patients undergoing bioprosthetic SAVR. This randomized, open-label, prospective multicenter trial will enroll 1,040 patients at 13 European sites. The primary endpoint is a composite of cardiovascular mortality, stroke and systemic embolism at 5 years. Secondary endpoints include cardiovascular mortality, stroke, systemic embolism, bleed fulfilling academic research consortium (BARC) criteria, hospitalization for decompensated heart failure and health economic evaluation. Sample size is based on 30% risk reduction in time to event analysis of primary endpoint. Prespecified reports include 30-day safety analysis focusing on AF occurrence and short-term outcomes and interim analyses at 1 and 3 years for primary and secondary outcomes. Additionally, substudies will be performed on the completeness of the closure using transesophageal echocardiography/cardiac computed tomography and long-term ECG recording at one year after the operation. © 2021 The Author(s)
|
|
| 35. |
- Konopelko, D., et al.
(författare)
-
Precambrian gold mineralization at Djamgyr in the Kyrgyz Tien Shan : Tectonic and metallogenic implications
- 2017
-
Ingår i: Ore Geology Reviews. - : Elsevier BV. - 0169-1368. ; 86, s. 537-547
-
Tidskriftsartikel (refereegranskat)abstract
- The Djamgyr gold deposit is located within the Neoproterozoic basement of the Middle Tien Shan terrane immediately west of the Talas-Fergana fault. The deposit comprises a system of auriferous quartz veins cross-cutting the Beshtor plagiogranite. The veins are surrounded by hydrothermal alteration aureoles and are oriented parallel to the Talas-Fergana fault. The Beshtor granite sampled in the vicinity of the deposit yielded a Neoproterozoic (Tonian) U-Pb zircon age of 815 ± 6 Ma, which is the first single grain zircon age of the Middle Tien Shan basement west of the Talas-Fergana fault. Ar-Ar dating of two muscovite fractions from the alteration aureoles of the auriferous quartz veins yielded ages of 804 ± 3 and 805 ± 3 Ma suggesting that the mineralization in the Djamgyr deposit occurred during the Neoproterozoic ca. 10 m.y. after emplacement of the Beshtor granite. The structural pattern of the auriferous quartz veins and the new geochronological data, combined with the results of previous structural studies, may tentatively constrain the age of pre-existing major fault possibly marking an inherited terrane boundary in the northern part of the present-day Talas-Fergana strike-slip fault. The discovery of Precambrian gold mineralization in the Middle Tien Shan suggests re-evaluation of the metallogenic potential of its Precambrian basement that occupies significant areas west and east of the Talas-Fergana fault.
|
|
| 36. |
|
|
| 37. |
- Nilsson, Mimmi K. M., et al.
(författare)
-
Precise U-Pb baddeleyite ages of mafic dykes and intrusions in southern West Greenland and implications for a possible reconstruction with the Superior craton
- 2010
-
Ingår i: Precambrian Research. - : Elsevier BV. - 0301-9268. ; 183:3, s. 399-415
-
Tidskriftsartikel (refereegranskat)abstract
- The Archaean block of southern Greenland constitutes the core of the North Atlantic craton (NAC) and is host to a large number of Precambrian mafic intrusions and dyke swarms, many of which are regionally extensive but poorly dated. For southern West Greenland, we present a U-Pb zircon age of 2990 +/- 13 Ma for the Amikoq mafic-ultramafic layered intrusion (Fiskefjord area) and four baddeleyite U-Pb ages of Precambrian dolerite dykes. Specifically, a dyke located SE of Ameralik Fjord is dated at 2499 +/- 2 Ma, similar to a previously reported Ar-40/Ar-39 age of a dyke in the Kangamiut area. For these and related intrusions of ca. 2.5 Ga age in southern West Greenland, we propose the name Kilaarsarfik dykes. Three WNW-trending dykes of the MD3 swarm yield ages of 2050 +/- 2 Ma, 2041 +/- 3 Ma and 2029 +/- 3 Ma. A similar U-Pb baddeleyite age of 2045 +/- 2 Ma is also presented for a SE-trending dolerite (Iglusuataliksuak dyke) in the Nain Province, the rifted western block of the NAC in Labrador. We speculate that the MD3 dykes and age-equivalent NNE-trending Kangamiut dykes of southern West Greenland, together with the Iglusuataliksuak dyke (after closure of the Labrador Sea) represent components of a single, areally extensive, radiating swarm that signaled the arrival of a mantle plume centred on what is presently the western margin of the North Atlantic craton. Comparison of the magmatic 'barcodes' from the Nain and Greenland portions of the North Atlantic craton with the established record from the north-eastern Superior craton shows matches at 2500 Ma, 2214 Ma, 2050-2030 Ma and 1960-1950 Ma. We use these new age constraints, together with orientations of the dyke swarms, to offer a preliminary reconstruction of the North Atlantic craton near the north-eastern margin of the Superior craton during the latest Archaean and early Palaeoproterozoic, possibly with the Core Zone craton of eastern Canada intervening. (C) 2010 Elsevier B.V. All rights reserved.
|
|
| 38. |
- Ravnskov, U., et al.
(författare)
-
Lack of an association or an inverse association between low-density-lipoprotein cholesterol and mortality in the elderly: a systematic review
- 2016
-
Ingår i: Bmj Open. - : BMJ. - 2044-6055. ; 6:6
-
Tidskriftsartikel (refereegranskat)abstract
- Objective It is well known that total cholesterol becomes less of a risk factor or not at all for all-cause and cardiovascular (CV) mortality with increasing age, but as little is known as to whether low-density lipoprotein cholesterol (LDL-C), one component of total cholesterol, is associated with mortality in the elderly, we decided to investigate this issue. Setting, participants and outcome measures We sought PubMed for cohort studies, where LDL-C had been investigated as a risk factor for all-cause and/or CV mortality in individuals 60years from the general population. Results We identified 19 cohort studies including 30 cohorts with a total of 68094 elderly people, where all-cause mortality was recorded in 28 cohorts and CV mortality in 9 cohorts. Inverse association between all-cause mortality and LDL-C was seen in 16 cohorts (in 14 with statistical significance) representing 92% of the number of participants, where this association was recorded. In the rest, no association was found. In two cohorts, CV mortality was highest in the lowest LDL-C quartile and with statistical significance; in seven cohorts, no association was found. Conclusions High LDL-C is inversely associated with mortality in most people over 60years. This finding is inconsistent with the cholesterol hypothesis (ie, that cholesterol, particularly LDL-C, is inherently atherogenic). Since elderly people with high LDL-C live as long or longer than those with low LDL-C, our analysis provides reason to question the validity of the cholesterol hypothesis. Moreover, our study provides the rationale for a re-evaluation of guidelines recommending pharmacological reduction of LDL-C in the elderly as a component of cardiovascular disease prevention strategies.
|
|
| 39. |
- Ravnskov, U., et al.
(författare)
-
LDL-C does not cause cardiovascular disease: a comprehensive review of the current literature
- 2018
-
Ingår i: Expert Review of Clinical Pharmacology. - : Informa UK Limited. - 1751-2433 .- 1751-2441. ; 11:10, s. 959-970
-
Tidskriftsartikel (refereegranskat)abstract
- Introduction: For half a century, a high level of total cholesterol (TC) or low-density lipoprotein cholesterol (LDL-C) has been considered to be the major cause of atherosclerosis and cardiovascular disease (CVD), and statin treatment has been widely promoted for cardiovascular prevention. However, there is an increasing understanding that the mechanisms are more complicated and that statin treatment, in particular when used as primary prevention, is of doubtful benefit. Areas covered: The authors of three large reviews recently published by statin advocates have attempted to validate the current dogma. This article delineates the serious errors in these three reviews as well as other obvious falsifications of the cholesterol hypothesis. Expert commentary: Our search for falsifications of the cholesterol hypothesis confirms that it is unable to satisfy any of the Bradford Hill criteria for causality and that the conclusions of the authors of the three reviews are based on misleading statistics, exclusion of unsuccessful trials and by ignoring numerous contradictory observations.
|
|
| 40. |
|
|
